{"OMIM ID": "OMIM:616172", "DISEASE": "Generalized Epilepsy With Febrile Seizures Plus, Type 9", "RECORD": "Rare disease patients have complex clinical representations. Patients with Generalized Epilepsy With Febrile Seizures Plus, Type 9 present clinical features that include:\n\nFebrile seizures\n\nGeneralized epilepsy\n\nCognitive impairment\n\nDevelopmental delay\n\nShort stature\n\nNeurological abnormalities\n\nThe Generalized Epilepsy With Febrile Seizures Plus, Type 9 is caused by mutations in the SCN1A gene.. Some special cases also present mutations in the SCN2A gene.\n\nGeneralized Epilepsy With Febrile Seizures Plus, Type 9 is a rare disease. It is estimated that the prevalence of this disease is less than 1 in 1,000,000 people.\n\nThe Generalized Epilepsy With Febrile Seizures Plus, Type 9 is inherited in an autosomal dominant manner. This means that the defective gene responsible for a disorder is located on an autosome (chromosome 13 is an autosome), and only one copy of the defective gene is sufficient to cause the disorder, when inherited from a parent who. The main symptomatic differences of Generalized Epilepsy With Febrile Seizures Plus, Type 9 from similar diseases is that the patients with Generalized Epilepsy With Febrile Seizures Plus, Type 9 present seizures, cognitive impairment, developmental delay and short stature.\n\nThe Generalized Epilepsy With Febrile Seizures Plus, Type 9 is caused by mutations in the SCN1A gene. Some special", "SUMMARY": " cases also present mutations in the SCN2A gene.\n\nThe Generalized Epilepsy With Febrile Seizures Plus, Type 9 is inherited in an autosomal dominant manner. This means that the defective gene responsible for a disorder"}